Department of Orthopedics, Ninghai Medical Center First Hospital, 142 Taoyuan Road, Ninghai County, Ningbo City, 315600, Zhejiang Province, China.
World J Surg. 2020 May;44(5):1412-1424. doi: 10.1007/s00268-020-05384-7.
Chlorhexidine (CH) and povidone-iodine (PI) are the most commonly used preoperative skin antiseptics at present. However, the prevention of the surgical site infection (SSI) and the incidence of skin adverse events do not reach a consistent statement and conclusion. This meta-analysis aimed to evaluate the efficacy of chlorhexidine and povidone-iodine in the prevention of postoperative surgical site infection and the incidence of corresponding skin adverse events.
Substantial studies related to "skin antiseptic" and "surgical site infection" were consulted on PUBMED, Web of Science, EMBASE, and CNKI. The primary outcome was the incidence of postoperative SSI. The secondary outcome was associated with skin adverse events. All data were analyzed with Revman 5.3 software.
A total of 30 studies were included, including 29,006 participants. This study revealed that chlorhexidine was superior to povidone-iodine in the prevention of postoperative SSI (risk ratio [RR], 0.65; 95% confidence interval [CI], 0.55-0.77; p < 0.00001, I = 57%). Further subgroup analysis showed that chlorhexidine was superior to povidone-iodine in the prevention of postoperative SSI in clean surgery (risk ratio [RR], 0.81; 95% confidence interval [CI], 0.67-0.98; p = 0.03), I = 28%) and clean-contaminated surgery (risk ratio [RR], 0.58; 95% confidence interval [CI], 0.47-0.73; p < 0.00001, I = 43%). However, there was no statistically significant difference in the incidence of skin adverse events between CH and PI groups.
Chlorhexidine was superior to povidone-iodine in preventing postoperative SSI, especially for the clean-contaminated surgery. However, there was no statistically significant difference in the incidence of skin adverse events between CH and PI groups.
氯己定(CH)和聚维酮碘(PI)是目前最常用的术前皮肤消毒剂。然而,预防手术部位感染(SSI)和皮肤不良事件的发生率并没有达成一致的说法和结论。本荟萃分析旨在评估氯己定和聚维酮碘在预防术后手术部位感染和相应皮肤不良事件发生率方面的疗效。
在 PUBMED、Web of Science、EMBASE 和 CNKI 上查阅了大量关于“皮肤消毒剂”和“手术部位感染”的相关研究。主要结局为术后 SSI 的发生率。次要结局为与皮肤不良事件相关的结局。所有数据均使用 Revman 5.3 软件进行分析。
共纳入 30 项研究,共 29006 名参与者。本研究表明,氯己定在预防术后 SSI 方面优于聚维酮碘(风险比[RR],0.65;95%置信区间[CI],0.55-0.77;p<0.00001,I=57%)。进一步的亚组分析表明,氯己定在预防清洁手术(RR,0.81;95%置信区间[CI],0.67-0.98;p=0.03,I=28%)和清洁污染手术(RR,0.58;95%置信区间[CI],0.47-0.73;p<0.00001,I=43%)中预防术后 SSI 方面优于聚维酮碘。然而,CH 和 PI 组之间皮肤不良事件的发生率没有统计学上的显著差异。
氯己定在预防术后 SSI 方面优于聚维酮碘,特别是在清洁污染手术中。然而,CH 和 PI 组之间皮肤不良事件的发生率没有统计学上的显著差异。